Macquarie Group’s ESSA Pharma EPIX Stock Holding History

Macquarie Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,106	Closed	-$38K	–	2589
2022 Q1	$38K	Hold	6,106	–	–	﹤0.01%	2234
2021 Q4	$87K	Hold	6,106	–	–	﹤0.01%	1980
2021 Q3	$49K	Buy	+6,106	New	+$97.1K	﹤0.01%	2241

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Macquarie Group's EPIX Position: Q2 2022 in Review

Macquarie Group sold out of ESSA Pharma (EPIX) in Q2 2022, closing a stake of 6,106 shares — an estimated $38K sold.

Macquarie Group first reported a position in EPIX in Q3 2021 and held it in 3 quarters. The position peaked at $87K in Q4 2021. 59 funds tracked by Wall St. Rank hold EPIX as of Q2 2022.

Macquarie Group reported no remaining ESSA Pharma position as of Q2 2022 after selling out during the quarter.
Macquarie Group sold 6,106 ESSA Pharma shares in Q2 2022, an estimated $38K.
Macquarie Group first reported a position in ESSA Pharma in Q3 2021 and held it in 3 quarters.
Macquarie Group's ESSA Pharma position peaked at $87K in Q4 2021.
59 funds tracked by Wall St. Rank held ESSA Pharma as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.